MValve technologies is dedicated to providing a solution for mitral regurgitation, an abnormal reversal of blood flow from the hearts left ventricle to the left atrium.
Cumulative Funding Raised Over Time ($)
Employees Over Time
MValve technologies Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Oct 9, 2015
www.globes.co.il
Boston Scientific confirms option to buy Israel's MValve
#Investment
Oct 9, 2015
www.meddeviceonline.com
Boston Scientific Pumps $200 Million Into MValve Technologies
#Investment #Acquisition
Oct 5, 2015
www.prnewswire.com
MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System
#Customers
Jul 7, 2014
www.fiercebiotech.com
Boston Scientific backs Israeli cardio device startup Mvalve with $15M
undefined
Jul 6, 2014
www.globes.co.il
Heart valve co Mvalve raises $15m from Boston Scientific